Abiopharma

New Form 8-K - OMEROS CORP Filed: 2025-07-25 AccNo: 0001104659-25-070554 Size: 564 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - GSK plc Filed: 2025-07-25 AccNo: 0001654954-25-008470 Size: 3 MB

New Form 424B5 - OMEROS CORP Filed: 2025-07-25 AccNo: 0001104659-25-070553 Size: 605 KB

New Form 8-K - CareCloud, Inc. Filed: 2025-07-25 AccNo: 0001493152-25-011403 Size: 291 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Lyell Immunopharma, Inc. Filed: 2025-07-25 AccNo: 0001193125-25-164853 Size: 523 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Dare Bioscience, Inc. Filed: 2025-07-25 AccNo: 0001493152-25-011402 Size: 200 KB Item 8.01: Other Events

New Form 6-K - Apollomics Inc. Filed: 2025-07-25 AccNo: 0001193125-25-164849 Size: 12 KB

New Form 8-K - HCA Healthcare, Inc. Filed: 2025-07-25 AccNo: 0000950170-25-098578 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Incannex Healthcare Inc. Filed: 2025-07-25 AccNo: 0001213900-25-067474 Size: 223 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - SENSIENT TECHNOLOGIES CORP Filed: 2025-07-25 AccNo: 0001140361-25-027250 Size: 4 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits